abstract |
The present invention is a novel tricyclic triazolic compound of formula (I) that exhibits great affinity for sigma receptors, in particular sigma-1 receptors, as well as methods for their preparation, compositions comprising the same, and, for example, treating pain related diseases Regarding their use as medicines for: |